Phase III allergy studies present unique challenges for sponsors, particularly when recruitment depends on a fixed seasonal window, sites must be activated rapidly across multiple countries, and any delay can push enrollment into the next season. When timelines are non-negotiable, sponsors need a delivery model that combines accelerated start-up, proactive site management, cross-functional coordination, and … Continued